Demographics (2)
- AGE - Subject age at enrollment (phv00533357.v1.p1)
- SEX - Biological sex (phv00533352.v1.p1)
Disease Events (1)
- PASI - Psoriasis area and severity index score of participant at time of collection (phv00533362.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00533356.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte type (phv00533360.v1.p1)
- BATCH - Batch of processing (phv00533363.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00533359.v1.p1)
- COLLECTION_DATE - Year of sample collection (phv00533366.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00533351.v1.p1)
- IS_TUMOR - Tumor status (phv00533361.v1.p1)
- LESION_STATUS - Status of sample site for psoriasis (phv00533364.v1.p1)
- METHODOLGY_USED - Methodology used (phv00533367.v1.p1)
- SAMPLE_ID - Sample ID (phv00533358.v1.p1)
- SAMPLE_ID - Sample ID (phv00533354.v1.p1)
- SUBJECT_ID - Subject ID (phv00533350.v1.p1)
- SUBJECT_ID - Subject ID (phv00533355.v1.p1)
- SUBJECT_ID - Subject ID (phv00533353.v1.p1)
- TREATMENT_DAY - Day of collection with regard to first day of treatment (phv00533365.v1.p1)